76P How to explain current reluctance against therapeutic de-escalation: Results of the exploratory qualitative phase of the mixed method research program CARTE therapy in older women with early breast cancer in France

M.K Bendiane,D Rey,A Richard Tallet,J Mancini

doi:10.1016/j.annonc.2022.03.092

76P How to explain current reluctance against therapeutic de-escalation: Results of the exploratory qualitative phase of the mixed method research program CARTE therapy in older women with early breast cancer in France

M.K Bendiane, D Rey + Show 2 more

Open Access

https://doi.org/10.1016/j.annonc.2022.03.092

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Publication Date: May 1, 2022

Affiliation: Economic & Social Sciences, Health Systems & Medical Informatics, Inserm, Aix-Marseille University, Institut de Recherche pour le Développement

#Therapy In Older Women #Breast Cancer In France + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Intraoperative radiotherapy (IORT) as a therapeutic de-escalation option is in France still limited and not recommended in national guidelines. In context of CARTE research program, a qualitative study was implemented among physiciansto better understand reluctance toward de-escalation treatment.

Full Text